tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
US Market
PCRX
Pacira Pharmaceuticals
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
PCRX Chart

Pacira Pharmaceuticals (PCRX) Stock News & Sentiment

Compare
368 Followers
Positive Outlook for Pacira Pharmaceuticals Amid Exparel Settlement and Strategic Growth Initiatives
Premium
Ratings
Positive Outlook for Pacira Pharmaceuticals Amid Exparel Settlement and Strategic Growth Initiatives
18d ago
PCRX
Pacira Pharmaceuticals Settles Patent Litigation with Fresenius
Premium
Company Announcements
Pacira Pharmaceuticals Settles Patent Litigation with Fresenius
19d ago
8K
PCRX
PCRX Lawsuit Alert! Class Action Lawsuit Against Pacira Biosciences, Inc.
Premium
Market News
PCRX Lawsuit Alert! Class Action Lawsuit Against Pacira Biosciences, Inc.
2M ago
PCRX
Pacira BioSciences Reports Record Revenues and Strategic Growth
Premium
Company Announcements
Pacira BioSciences Reports Record Revenues and Strategic Growth
2M ago
PCRX
Pacira Pharmaceuticals: Strategic Initiatives and Financial Outlook Drive Buy Rating
Premium
Ratings
Pacira Pharmaceuticals: Strategic Initiatives and Financial Outlook Drive Buy Rating
2M ago
PCRX
Pacira Pharmaceuticals: Undervalued with Strong Growth Potential and Legal Protections Against Generic Competition
Premium
Ratings
Pacira Pharmaceuticals: Undervalued with Strong Growth Potential and Legal Protections Against Generic Competition
2M ago
PCRX
Pacira BioSciences Reports Record Revenue Amid Strategic Growth
Premium
Company Announcements
Pacira BioSciences Reports Record Revenue Amid Strategic Growth
2M ago
PCRX
More PCRX News >

PCRX News on the Web

Pacira BioSciences Inc (PCRX) Announces Promising 104-Week Data for Gene Therapy Candidate ...
GuruFocus News
Bullish
Why Pacira (PCRX) is Poised to Beat Earnings Estimates Again
Zacks
Bullish
Why Pacira BioSciences, Inc.amp;#8217;s (PCRX) Stock Is Up 5.48%
AAII
Neutral
Pacira BioSciences Announces Repurchase Authorization
rttnews
Neutral
Pacira (PCRX) Announces New $300M Share Repurchase Plan | PCRX Stock News
GuruFocus News
Neutral
Pacira BioSciences Reaffirms Commitment to Enhancing Value for All Shareholders | PCRX Stock News
GuruFocus News
Bullish
The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb
Zacks
Neutral
Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More
Zacks
Neutral

News Score - Last 7 Days

Positive
PCRX
Sector Average
Media Buzz
This Week3 articles
Weekly Average4.25 articles
News Sentiment
This Week100%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PCRX’s Media Buzz Sentiment?
3 articles about PCRX were published this week. In an average week, 4.25 articles are published.
    What is PCRX’s weekly average amount of articles?
    In an average week, 4.25 articles about PCRX are published.
      What is PCRX’s News Sentiment?
      100% of articles about PCRX were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        RMDResmed
        HRTXHeron Therapeutics
        HCMHUTCHMED
        ISRGIntuitive Surgical
        EHCEncompass Health
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing